Amit Bahl is Consultant Clinical Oncologist and Clinical Director based at The Bristol Haematology & Oncology Centre.

Dr Bahl has a special interest in breast and urological cancers.

He has led and developed the prostate brachytherapy service at Bristol.  He has been an expert adviser to NICE for the technology appraisal on new drugs and an external service reviewer. He has been awarded the fellowship of the Royal College of Physicians.

Dr Bahl is a current member of the National Cancer Research Institute for prostate and bladder cancer, and has supervised several research projects. He has previously been in the NCRI Renal clinical studies group. He is an Executive Committee member of the British Uro-oncology group. Dr Bahl is actively involved in research into breast, prostate and bladder cancers, participates in clinical trials and regularly publishes articles and has several presentations at national and international meetings.

In 2012, Dr Bahl was awarded the Cochrane Shanks Jalil Professorship by the Royal College of Radiologists, London.